Private sector funded total drug spending in Canada by top drug classes 2013
This statistic shows the top 10 drug classes in Canada based on total drug program expenditures funded by the private sector in 2013. In that year, the private sector funded some 503.2 million Canadian dollars for HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.